Management change at Actelion
Isaac Kobrin to take newly created position of Chief Medical Officer, Guy Braunstein to join as new Head of Clinical Development
As a consequence, Isaac will hand over his position as Head of Clinical Development to Guy Braunstein. Guy joins Actelion having served as Chief Medical Officer at Merck Serono and, before this, as Chief Medical Officer at Serono International. Guy will join Actelion's Executive Committee adding his more than 20 years of experience to Actelion's senior management decision-making committee.
Guy Braunstein is a French citizen with an MD and is specialized in respiratory medicine. He has a PhD in life science. Guy joins Actelion from Merck Serono, where he was the Chief Medical Office, having served for 4 years before that as Chief Medical Officer at Serono International. His more than 20 years in the pharmaceutical industry spans a wide range of experience from affiliate Medical Director and Global Medical Affairs through to Research and Development roles. Guy has worked in both large pharmaceutical and biotech environments in companies such as Astra, Glaxo-Wellcome, GSK, Fisons, Rhône-Poulenc Rorer and Chiron. During this time he built experience in multiple therapeutic areas, in particular respiratory, inflammation and autoimmune disorders, multiple sclerosis and oncology.
Isaac Kobrin is an internist educated in Israel with further training (Fullbright Fellowship) at the Ochsner Medical Foundation in New Orleans, LA, USA, mainly in the cardiovascular and nephrology fields. He joined the clinical cardiovascular development department at F. Hoffmann-La Roche Ltd in 1989. During his 10 years at Roche he was responsible for the worldwide clinical development of key compounds within the company's cardiovascular portfolio (from Phase 1 to marketing approval). In 1997 he became Group Leader of the cardiovascular development group. Isaac joined Actelion in September 1999 as Senior Vice President, Head of Clinical Development.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.